User profiles for Bettina Nadorp
 | Bettina Nadorp, Ph.D.Assistant Professor, NYU Grossman School of Medicine Verified email at nyulangone.org Cited by 725 |
Single-cell chromatin accessibility profiling of glioblastoma identifies an invasive cancer stem cell population associated with lower survival
Chromatin accessibility discriminates stem from mature cell populations, enabling the
identification of primitive stem-like cells in primary tumors, such as glioblastoma (GBM) where self-…
identification of primitive stem-like cells in primary tumors, such as glioblastoma (GBM) where self-…
Transfer RNA fragments replace microRNA regulators of the cholinergic poststroke immune blockade
Stroke is a leading cause of death and disability. Recovery depends on a delicate balance
between inflammatory responses and immune suppression, tipping the scale between brain …
between inflammatory responses and immune suppression, tipping the scale between brain …
Synaptopathies: synaptic dysfunction in neurological disorders–A review from students to students
…, M Haidar, OM Ijomone, B Nadorp… - Journal of …, 2016 - Wiley Online Library
Synapses are essential components of neurons and allow information to travel coordinately
throughout the nervous system to adjust behavior to environmental stimuli and to control …
throughout the nervous system to adjust behavior to environmental stimuli and to control …
An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia
Acute myeloid leukemia (AML) is a hematopoietic malignancy with poor prognosis and limited
treatment options. Here we provide a comprehensive census of the bone marrow immune …
treatment options. Here we provide a comprehensive census of the bone marrow immune …
A membrane-associated MHC-I inhibitory axis for cancer immune evasion
Immune-checkpoint blockade has revolutionized cancer treatment, but some cancers, such
as acute myeloid leukemia (AML), do not respond or develop resistance. A potential mode of …
as acute myeloid leukemia (AML), do not respond or develop resistance. A potential mode of …
[PDF][PDF] TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity
Clonal hematopoiesis (CH) is an aging-associated condition characterized by the clonal
outgrowth of pre-leukemic cells that acquire specific mutations. Although individuals with CH …
outgrowth of pre-leukemic cells that acquire specific mutations. Although individuals with CH …
[PDF][PDF] Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation
Lack of cellular differentiation is a hallmark of many human cancers, including acute myeloid
leukemia (AML). Strategies to overcome such a differentiation blockade are an approach …
leukemia (AML). Strategies to overcome such a differentiation blockade are an approach …
[HTML][HTML] Alzheimer's brains show inter-related changes in RNA and lipid metabolism
Alzheimer's disease (AD) involves changes in both lipid and RNA metabolism, but it
remained unknown if these differences associate with AD's cognition and/or post-mortem …
remained unknown if these differences associate with AD's cognition and/or post-mortem …
[HTML][HTML] Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders
MicroRNAs (miRNAs) can notably control many targets each and regulate entire cellular
pathways, but whether miRNAs can regulate complete neurotransmission processes is largely …
pathways, but whether miRNAs can regulate complete neurotransmission processes is largely …
Accessibility over transposable elements reveals genetic determinants of stemness properties in normal and leukemic hematopoiesis
Despite most acute myeloid leukemia (AML) patients achieving complete remission after
induction chemotherapy, two thirds of patients will relapse with fatal disease within 5 years. …
induction chemotherapy, two thirds of patients will relapse with fatal disease within 5 years. …
